D.E. Shaw & Co’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $123M | Sell |
2,417,000
-1,694,100
| -41% | -$79M | 0.1% | 308 |
|
|
2025
Q4 | $121M | Sell |
4,111,100
-223,600
| -5% | -$6.07M | 0.09% | 347 |
|
|
2025
Q3 | $112M | Buy |
4,334,700
+552,000
| +15% | +$15.4M | 0.09% | 365 |
|
|
2025
Q2 | $104M | Buy |
3,782,700
+406,200
| +12% | +$10.7M | 0.1% | 320 |
|
|
2025
Q1 | $95.7M | Buy |
3,376,500
+1,415,900
| +72% | +$50.2M | 0.11% | 292 |
|
|
2024
Q4 | $81.5M | Buy |
1,960,600
+912,500
| +87% | +$43.6M | 0.09% | 389 |
|
|
2024
Q3 | $70M | Buy |
1,048,100
+155,700
| +17% | +$14.3M | 0.09% | 385 |
|
|
2024
Q2 | $106M | Sell |
892,400
-35,900
| -4% | -$4.54M | 0.15% | 235 |
|
|
2024
Q1 | $98.9M | Buy |
928,300
+230,900
| +33% | +$23.3M | 0.13% | 265 |
|
|
2023
Q4 | $69.4M | Buy |
697,400
+190,100
| +37% | +$16M | 0.1% | 374 |
|
|
2023
Q3 | $52.4M | Buy |
507,300
+91,000
| +22% | +$10.2M | 0.09% | 411 |
|
|
2023
Q2 | $50.6M | Sell |
416,300
-90,500
| -18% | -$12.1M | 0.08% | 427 |
|
|
2023
Q1 | $77.8M | Buy |
506,800
+196,900
| +64% | +$32.5M | 0.13% | 284 |
|
|
2022
Q4 | $55.7M | Sell |
309,900
-57,900
| -16% | -$9.47M | 0.09% | 386 |
|
|
2022
Q3 | $43.5M | Buy |
367,800
+15,100
| +4% | +$2.29M | 0.08% | 455 |
|
|
2022
Q2 | $50.4M | Sell |
352,700
-168,600
| -32% | -$24.1M | 0.08% | 389 |
|
|
2022
Q1 | $89.8M | Buy |
521,300
+51,000
| +11% | +$8.59M | 0.12% | 270 |
|
|
2021
Q4 | $119M | Sell |
470,300
-235,300
| -33% | -$68.8M | 0.15% | 218 |
|
|
2021
Q3 | $272M | Buy |
705,600
+171,600
| +32% | +$63.3M | 0.35% | 56 |
|
|
2021
Q2 | $125M | Buy |
534,000
+189,600
| +55% | +$33.9M | 0.14% | 205 |
|
|
2021
Q1 | $45.1M | Buy |
344,400
+195,900
| +132% | +$28.4M | 0.06% | 531 |
|
|
2020
Q4 | $15.5M | Buy |
148,500
+18,100
| +14% | +$1.83M | 0.02% | 1095 |
|
|
2020
Q3 | $9.23M | Sell |
130,400
-228,600
| -64% | -$15.9M | 0.01% | 1292 |
|
|
2020
Q2 | $23.1M | Buy |
+359,000
| New | +$19.7M | 0.03% | 708 |
|
Other funds holding MRNA
VCM
VPM
